With a test group of 16 of the most dire cases of adult B-cell acute lymphoblastic leukemia, or B-ALL, a cell therapy approach that boosts the patient's own immune system managed to guide nearly 90 percent into complete remission.
Pioneering Cell Therapy Achieves Complete Remission In Patients With End-Stage Leukemia
Singularity Hub - 19 Feb 2014 23:00
With a test group of 16 of the most dire cases of adult B-cell acute lymphoblastic leukemia, or B-ALL, a cell therapy approach that boosts the patient's own immune system managed to guide nearly 90 percent into complete remission.
Share this Article
Recommended